ARTICLE | Clinical News
SNF472: Phase II started
October 24, 2016 7:00 AM UTC
Sanifit began an open-label, international Phase II trial to evaluate SNF472 given over 3 months in 15 newly diagnosed patients. Calciphylaxis is a rare condition characterized by vascular calcificati...